赛恩斯(688480) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥170,297,088.13, representing a 63.46% increase compared to ¥104,184,107.78 in the same period last year[3] - The net profit attributable to shareholders decreased by 77.68% to ¥17,725,068.02 from ¥79,420,238.21 year-on-year[3] - Basic and diluted earnings per share fell by 77.38% to ¥0.19 from ¥0.84 in the previous year[3] - Total operating revenue for Q1 2025 reached ¥170,297,088.13, a 63.4% increase from ¥104,184,107.78 in Q1 2024[16] - Net profit attributable to shareholders of the parent company for Q1 2025 was ¥17,725,068.02, a decrease of 77.7% compared to ¥79,420,238.21 in Q1 2024[18] - Basic earnings per share for Q1 2025 was ¥0.19, down from ¥0.84 in Q1 2024[19] - The company reported a total comprehensive income of ¥20,410,532.73 for Q1 2025, down from ¥80,856,749.26 in Q1 2024[19] Research and Development - Research and development expenses totaled ¥11,535,438.40, an increase of 69.25% from ¥6,815,638.47 in the same period last year[3] - The proportion of R&D expenses to operating revenue increased by 0.23 percentage points to 6.77% from 6.54%[4] Cash Flow - The net cash flow from operating activities was negative at -¥52,181,166.86, compared to -¥22,550,454.83 in the same period last year, indicating increased cash outflows[3] - Cash inflow from operating activities in Q1 2025 totaled ¥199,871,436.70, compared to ¥159,174,110.84 in Q1 2024, reflecting a 25.6% increase[22] - Cash outflow from operating activities for Q1 2025 was ¥252,052,603.56, an increase from ¥181,724,565.68 in Q1 2024[22] - The net cash flow from operating activities was -$52.18 million, compared to -$22.55 million in the previous period[23] - The net increase in cash and cash equivalents was -$191.72 million, compared to -$312.99 million in the previous period[24] - The ending balance of cash and cash equivalents stood at $205.11 million, down from $220.38 million year-over-year[24] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,865,158,022.44, a 2.14% increase from ¥1,826,160,633.21 at the end of the previous year[4] - Current liabilities totaled RMB 634,739,278.23, compared to RMB 611,353,489.20, showing an increase of about 3.8%[14] - The company's long-term borrowings decreased to RMB 9,000,000.00 from RMB 14,000,000.00, a reduction of approximately 35.7%[14] - The total liabilities increased to RMB 643,739,278.23, compared to the previous period, indicating a growth trend in financial obligations[14] - The total liabilities as of the latest reporting period amounted to ¥729,691,085.25, compared to ¥712,184,376.33 in the previous period[15] Investment Activities - The company reported a significant decrease in investment income due to the previous year's acquisition of Fujian Zijinlong Chemical Co., which impacted net profit[6] - Cash inflow from investment activities totaled $208.64 million, down from $223.86 million year-over-year[23] - Cash outflow from investment activities was $353.49 million, a decrease from $515.52 million in the prior period[23] - Cash paid for investment activities was $336.72 million, slightly down from $340 million last year[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 3,586[8] - Total equity attributable to shareholders of the parent company was ¥1,094,516,967.20, an increase from ¥1,074,395,389.39[15]